Assessing the possible association between MTHFR (rs1801133) and GPx-1 (rs1050450) polymorphisms with the risk of type 2 diabetes, diabetic neuropathy, and diabetic retinopathy
- PMID: 38683407
- DOI: 10.1007/s11033-024-09519-0
Assessing the possible association between MTHFR (rs1801133) and GPx-1 (rs1050450) polymorphisms with the risk of type 2 diabetes, diabetic neuropathy, and diabetic retinopathy
Abstract
Purpose: Oxidative stress in chronic hyperglycemia could injure the tissues and onset of diabetes-related complications like retinopathy and neuropathy. This study investigates the association between methylenetetrahydrofolate reductase (MTHFR) and glutathione peroxidase (GPx) genetic variants with these complications.
Methods: In this case-control study, 400 individuals, including 100 healthy subjects and 300 patients with type 2 diabetes mellitus (T2DM) in three subgroups: with retinopathy(n = 100), with neuropathy(n = 100), and without complication (n = 100) from West Iran, were studied. MTHFR (rs1801133) and GPx-1 (rs1050450) variants were identified by the PCR-RFLP method. The plasma levels of GPx activity, glutathione, malondialdehyde (MDA), total antioxidant capacity (TAC), and total oxidative stress (TOS) were measured by chemical methods.
Results: Higher BMI, TOS and MDA levels were observed in patients with neuropathy compared to other patients and controls. Diabetic patients with neuropathy had lower levels of glutathione (7.8 ± 4.5; P < 0.001), GPx activity (39.5 ± 8.5; P < 0.001), and TAC (703.1 ± 129.1; P = 0.0001) in comparison with other groups. The patients without complication and retinopathic patients had higher plasma levels of glutathione (12.2 ± 2.4; p = 0.02) and TAC (793.4 ± 124.6; P < 0.001), respectively. MTHFR TT genotype significantly correlated with lower levels of TOS (3.5 ± 1.1; P < 0.001) and OSI (0.0050 ± 0.001; P < 0.001). Subjects with the GPx-1 TT genotype had higher levels of MDA (6.8 ± 2.5; P = 0.02) and lower levels of TOS (3.7 ± 1.6; P < 0.001), which is statistically significant. TT genotype of MTHFR was associated with 3.9 fold (95% CI 1.04-4.76; P = 0.0436) increased risk of neuropathy. Also, GPx-1 CT genotype increased the risk of retinopathy [OR = 2.7 (95% CI = 1.38-5.44; P = 0.0039)].
Conclusion: The MTHFR TT genotype increased the risk of neuropathy in diabetic patients significantly. The GPx-1 CT genotype is related to increased retinopathy risk among diabetic patients. Both MTHFR and Gpx-1 TT genotypes were associated with higher BMI levels.
Keywords: GPx-1; MTHFR; Oxidative stress; Type 2 diabetes mellitus.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
5,10-methylenetetrahydrofolate reductase C677T gene polymorphism as a risk factor for premature coronary artery disease in patients with type 2 diabetes mellitus.Front Endocrinol (Lausanne). 2025 Jan 22;15:1502497. doi: 10.3389/fendo.2024.1502497. eCollection 2024. Front Endocrinol (Lausanne). 2025. PMID: 39911235 Free PMC article.
-
Impacts of Methylenetetrahydrofolate Reductase Genotypes on Hallux Valgus.In Vivo. 2025 Jan-Feb;39(1):172-179. doi: 10.21873/invivo.13815. In Vivo. 2025. PMID: 39740879 Free PMC article.
-
The association between vitamin D receptor gene polymorphism FokI and type 2 diabetic kidney disease and its molecular mechanism: a case control study.BMC Med Genomics. 2024 Dec 18;17(1):288. doi: 10.1186/s12920-024-02061-9. BMC Med Genomics. 2024. PMID: 39696279 Free PMC article.
-
Systematic review on the relationship between genetic polymorphisms of methylenetetrahydrofolate reductase and esophageal squamous cell carcinoma.Asian Pac J Cancer Prev. 2011;12(7):1861-6. Asian Pac J Cancer Prev. 2011. PMID: 22126580 Review.
-
Gabapentin for chronic neuropathic pain and fibromyalgia in adults.Cochrane Database Syst Rev. 2014 Apr 27;2014(4):CD007938. doi: 10.1002/14651858.CD007938.pub3. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2017 Jun 09;6:CD007938. doi: 10.1002/14651858.CD007938.pub4. PMID: 24771480 Free PMC article. Updated. Review.
Cited by
-
Mitigating diabetes associated with reactive oxygen species (ROS) and protein aggregation through pharmacological interventions.RSC Adv. 2024 May 29;14(25):17448-17460. doi: 10.1039/d4ra02349h. eCollection 2024 May 28. RSC Adv. 2024. PMID: 38813124 Free PMC article. Review.
-
Genetic insights and emerging therapeutics in diabetic retinopathy: from molecular pathways to personalized medicine.Front Genet. 2024 Aug 22;15:1416924. doi: 10.3389/fgene.2024.1416924. eCollection 2024. Front Genet. 2024. PMID: 39246572 Free PMC article. Review.
References
-
- Baum P, Toyka KV, Blüher M, Kosacka J, Nowicki M (2021) Inflammatory mechanisms in the pathophysiology of Diabetic Peripheral Neuropathy (DN)-New aspects. Int J Mol Sci. ;22(19)
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous